Atlas Venture Life Science Advisors as of March 31, 2026
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 48.3 | $381M | 4.6M | 83.29 | |
| Dyne Therapeutics Common Stock (DYN) | 21.0 | $166M | 9.1M | 18.13 | |
| Sionna Therapeutics Common Stock (SION) | 15.2 | $120M | 3.0M | 40.09 | |
| Disc Medicine Common Stock (IRON) | 12.3 | $97M | 1.5M | 63.94 | |
| Q32 Bio Common Stock (QTTB) | 1.7 | $13M | 2.1M | 6.42 | |
| Korro Bio Common Stock (KRRO) | 1.6 | $13M | 1.1M | 11.32 |
